EMR Jan 2024 90.000 call
| Previous close | 9.84 |
| Open | 9.84 |
| Bid | 9.40 |
| Ask | 9.90 |
| Strike | 90.00 |
| Expiry date | 2024-01-19 |
| Day's range | 9.84 - 9.84 |
| Contract range | N/A |
| Volume | |
| Open interest | 743 |
ZacksHere's Why You Should Hold on to Emerson (EMR) Stock for Now
Strength across the process and hybrid end markets, improving supply chains and expansion initiatives bode well for Emerson (EMR). The company's shareholder-friendly policies are encouraging.
PR NewswireOtis Appoints Tracy Embree President, Otis Americas and Enrique Miñarro Viseras as President, Otis Europe, Middle East and Africa
Otis Worldwide Corporation (NYSE: OTIS) announces the appointment of Tracy Embree as President, Otis Americas and Enrique Miñarro Viseras as President, Otis Europe, Middle East and Africa (EMEA), reporting directly to Otis Chair, CEO & President, Judy Marks. Effective Oct. 1, Embree will succeed Jim Cramer and Miñarro Viseras will succeed Bernardo Calleja. Otis is the world's leading company for elevator and escalator manufacturing, installation and service.
PR NewswireEmerson Ventures Invests in First Resonance
Emerson (NYSE: EMR) today announced it has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in First Resonance, a Los Angeles-based start-up transforming manufacturing with its ION Factory Operating System (OS).
